G1. Will CMS monitor the participation of individuals in a CMS-approved Cytology Proficiency Testing Program?
Yes. CMS will monitor the enrollment and participation of cytotechnologists and pathologists in a CMS-Approved Cytology Proficiency Testing Program.
G2. What happens if I fail my proficiency test and my laboratory does not take the appropriate corrective actions to help me pass the retest?
If the laboratory where you are tested does not ensure that you participate in an annual testing event, or that you are retested or the laboratory fails to take the appropriate remedial actions as described in Question D6, CMS will initiate intermediate sanctions against the laboratory or limit the laboratory’s CLIA certificate for cytology, and if applicable, terminate the laboratory’s Medicare approval for cytology. CMS suggests that laboratory management be made aware of the consequences of the laboratory’s failure to be enrolled and tested in a CMS-Approved Cytology Proficiency Testing Program, and take appropriate corrective actions in the event of test failure.